We are live on ! Find out more
KXA

KPCB XII Associates Portfolio holdings

AUM $738K
1-Year Est. Return 3.15%
This Fund
S&P 500
This Quarter Est. Return
+14.59%
1 Year Est. Return
-3.15%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$62.3M
AUM Growth
-$74.9M
Cap. Flow
-$99.3M
Cap. Flow %
-159.43%
Top 10 Hldgs %
100%
Holding
3
New
Increased
Reduced
2
Closed

Top Buys

No buys this quarter

Sector Composition

Rank Sector Weight
1 Technology 63.03%
2 Healthcare 36.12%
3 Materials 0.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CBLK
1
DELISTED
Carbon Black, Inc. Common Stock
CBLK
$39.3M 63.03%
2,815,453
-1,813,200
-39% -$25.9M
INSP icon
2
Inspire Medical Systems
INSP
$1.46B
$22.5M 36.12%
396,406
-1,359,900
-77% -$73.5M
AMRS
3
DELISTED
Amyris Inc.
AMRS
$528K 0.85%
252,834

Similar funds

KPCB XII Associates's Q1 2019 Portfolio in Review

As of Q1 2019, KPCB XII Associates held 3 positions worth $62.3M, down 55% from $137M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

KPCB XII Associates withdrew a net $99.3M in Q1 2019, reducing 2 holdings. Its largest reduction was Inspire Medical Systems, cutting an estimated $73.5M.

By sector, the portfolio is most concentrated in Technology at 63% of assets, up from 45% a quarter earlier, followed by Healthcare and Materials.

  • KPCB XII Associates's biggest Q1 2019 reduction was Inspire Medical Systems, cutting an estimated $73.5M.
  • KPCB XII Associates's ten largest holdings make up 100% of its $62.3M portfolio in Q1 2019.
  • KPCB XII Associates opened 0 new positions and closed 0 in Q1 2019.
  • KPCB XII Associates's portfolio value fell 55% quarter-over-quarter to $62.3M.

Based on KPCB XII Associates's 13F filing for Q1 2019, filed 25 Apr 2019.